Log In
Print
BCIQ
Print
Print this Print this
 

esketamine (AM-101)

  Manage Alerts
Collapse Summary General Information
Company Auris Medical Holding AG
DescriptionIntratympanicly injected non-competitive antagonist of NMDA receptors
Molecular Target NMDA receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationTinnitus
Indication DetailsTreat acute peripheral (inner ear) tinnitus; Treat post acute inner ear tinnitus
Regulatory Designation

U.S. - Special Protocol Assessment (Treat acute peripheral (inner ear) tinnitus)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today